EMCOR Beats and Raises — Then the Stock Drops

Short positioning tells a less alarming story than the price action implies. Short interest climbed roughly 13% over the week to 1.98% of the free float — a meaningful move in percentage terms but still a modest absolute level. The week-long build, which began before the print, looks more like tactical hedging ahead of an event than a conviction short thesis. Borrow conditions support that reading: the cost to borrow has edged up 34% over the week to 0.46%, still a negligible rate that signals no real squeeze risk. Availability remains loose, with the ORTEX short score running at a low 31.5 on a 0–100 scale — well short of the elevated-pressure territory that would warrant concern. Options sentiment is similarly relaxed, with the put/call ratio at 0.54, almost exactly in line with its 20-day average and far below the 52-week high of 1.0 reached at the cautious end of the market last autumn.

The Street was broadly bullish heading into the print, and the recent analyst cadence reinforces that. UBS raised its target to $945 in early March while maintaining Buy; DA Davidson and Stifel both lifted targets after Q4, taking them to $900 and $814 respectively. Cantor Fitzgerald initiated coverage in March with an Overweight and an $848 target. The notable outlier in the room is Goldman Sachs, which holds a Neutral rating — it raised its target from $495 to $675 in October 2025 but remains sidelined on valuation. The mean price target from those recent changes sits around $890, implying modest upside from the current $833 level. The forward PE running at roughly 27.8x and EV/EBITDA at 18.2x are not cheap multiples for a construction-services business, but the RPO backlog and data-centre exposure have historically commanded a premium. The EPS surprise factor score ranks at the 86th percentile — confirming a track record of beating estimates that the market has been pricing in.

The insider picture is worth a note of context, though not an alarm. In late February and early March, CEO Guzzi sold approximately 44,000 shares across two transactions for roughly $32 million in total proceeds. CFO Nalbandian and the Chief Administration Officer also sold in late February, though in far smaller size. These were the first notable insider sales in recent months and arrived at prices between $725 and $730 — well below today's level — suggesting opportunistic selling rather than a signal about business trajectory. The top institutional holders, led by Vanguard at 11.9% and BlackRock at 8.9%, added modestly to positions through Q1.

What to watch next is whether the short interest build that started mid-week before earnings now reverses — the event has passed, the results were strong, and there is no obvious fundamental thesis supporting a persistent 2% short. The gap between the strong RPO backlog and the market's reluctance to re-rate higher is the central question going into Q2.